(Q46478572)

22 December 2017

title

Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer (English)

1 reference

22 December 2017

main subject

multiple drug resistance

1 reference

inferred from title

Pseudomonas aeruginosa

1 reference

inferred from title

author

Kenneth V. I. Rolston

10

object named as

Kenneth Rolston

1 reference

22 December 2017

author name string

Norio Ohmagari

1

1 reference

22 December 2017

Hend Hanna

2

1 reference

22 December 2017

Linda Graviss

3

1 reference

22 December 2017

Brenda Hackett

4

1 reference

22 December 2017

Cheryl Perego

5

1 reference

22 December 2017

Virginia Gonzalez

6

1 reference

22 December 2017

Tanya Dvorak

7

1 reference

22 December 2017

Holly Hogan

8

1 reference

22 December 2017

Ray Hachem

9

1 reference

22 December 2017

Issam Raad

11

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

22 December 2017

published in

Cancer

1 reference

22 December 2017

volume

104

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

205-212

1 reference

22 December 2017

beta-Lactam resistance in gram-negative bacteria: global trends and clinical impact

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

Selective imipenem resistance in Pseudomonas aeruginosa associated with diminished outer membrane permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002, issued August 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Development of resistance to imipenem among nosocomial isolates of Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Multi-drug resistant Pseudomonas aeruginosa outbreak in a burns unit--an infection control study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Investigation of an outbreak of nosocomial infection due to a multiply drug-resistant strain of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Transmission of a multiresistant Pseudomonas aeruginosa strain at a German University Hospital

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

CDC definitions for nosocomial infections, 1988

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Editorial Commentary: Looking for Risk Factors for the Acquisition of Antibiotic Resistance: A 21st‐Century Approach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Carbapenemases: a problem in waiting?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Bacterial infection in exacerbated COPD with changes in sputum characteristics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21115

7 January 2021

Identifiers

DOI

10.1002/CNCR.21115

1 reference

22 December 2017

PubMed ID

15880433

1 reference

22 December 2017